Frequency Therapeutics Inc.

10.12+0.3600+3.69%Vol 788.31K1Y Perf -32.78%
Apr 22nd, 2021 16:00 DELAYED
BID9.95 ASK10.20
Open9.83 Previous Close9.76
Pre-Market- After-Market-
 - -%  - -
Target Price
21.67 
Analyst Rating
Moderate Buy 2.00
Potential %
114.13 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     54.38
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     52.91
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap345.88M 
Earnings Rating
Price Range Ratio 52W %
5.45 
Earnings Date
13th May 2021

Today's Price Range

9.7310.60

52W Range

7.3458.37

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
5.53%
1 Month
26.66%
3 Months
-73.87%
6 Months
-53.94%
1 Year
-32.78%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FREQ10.120.36003.69
AAPL131.94-1.5600-1.17
GOOG2 267.92-25.3700-1.11
MSFT257.17-3.4100-1.31
XOM55.27-0.7300-1.30
WFC42.70-0.5400-1.25
JNJ165.18-1.4100-0.85
FB296.52-4.9500-1.64
GE13.410.06000.45
JPM147.37-3.1700-2.11
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.30-0.300.00
Q03 2020-0.32-0.1650.00
Q02 2020-0.22-0.1913.64
Q01 2020-0.25-0.1636.00
Q04 2019--0.19-
Q03 2019-3.42-0.7378.65
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date13th May 2021
Estimated EPS Next Report-0.27
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume788.31K
Shares Outstanding34.18M
Trades Count7.38K
Dollar Volume10.44M
Avg. Volume1.21M
Avg. Weekly Volume746.70K
Avg. Monthly Volume2.14M
Avg. Quarterly Volume1.44M

Frequency Therapeutics Inc. (NASDAQ: FREQ) stock closed at 10.12 per share at the end of the most recent trading day (a 3.69% change compared to the prior day closing price) with a volume of 790.69K shares and market capitalization of 345.88M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 47 people. Frequency Therapeutics Inc. CEO is David L. Lucchino.

The one-year performance of Frequency Therapeutics Inc. stock is -32.78%, while year-to-date (YTD) performance is -71.3%. FREQ stock has a five-year performance of %. Its 52-week range is between 7.34 and 58.37, which gives FREQ stock a 52-week price range ratio of 5.45%

Frequency Therapeutics Inc. currently has a PE ratio of -11.70, a price-to-book (PB) ratio of 1.70, a price-to-sale (PS) ratio of 10.83, a price to cashflow ratio of 28.20, a PEG ratio of 2.32, a ROA of -10.87%, a ROC of -32.84% and a ROE of -14.73%. The company’s profit margin is -72.67%, its EBITDA margin is -71.80%, and its revenue ttm is $29.72 Million , which makes it $0.87 revenue per share.

Of the last four earnings reports from Frequency Therapeutics Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.27 for the next earnings report. Frequency Therapeutics Inc.’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for Frequency Therapeutics Inc. is Moderate Buy (2), with a target price of $21.67, which is +114.13% compared to the current price. The earnings rating for Frequency Therapeutics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Frequency Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Frequency Therapeutics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 23.02, ATR14 : 2.75, CCI20 : 54.28, Chaikin Money Flow : 0.05, MACD : -10.14, Money Flow Index : 71.58, ROC : 0.60, RSI : 38.00, STOCH (14,3) : 23.92, STOCH RSI : 1.00, UO : 43.34, Williams %R : -76.08), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Frequency Therapeutics Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Strong Buy
1.00
Strong Buy
1.00

Frequency Therapeutics Inc.

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.

CEO: David L. Lucchino

Telephone: +1 866 389-1970

Address: 19 Presidential Way, Woburn 01801, MA, US

Number of employees: 47

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

52%48%

News

Stocktwits